Eli Lilly (LLY) stock is in focus as Nimbus Therapeutics expands its research deal to develop an oral obesity drug in a deal ...

Bihar Forest Guard Recruitment 2024 Notification Application ...

Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest.

Matt Korda, the associate director of the Nuclear Information Project at the Federation of American Scientists, assisted USA ...